treatment options

Research has been going on worldwide since the 1970s to fight tumors with dendritic cells. For this, Dr. Steinman and his team won the 2011 Nobel Prize in Medicine for discovering dendritic cells and their potential use in cancer.

The customer/patient request for immunological cancer therapies is growing steadily. Genetics and biology, with their possibilities of producing a customized vaccine for cancer therapy from the blood of the affected patients, is not only an alternative, in addition to standard therapy measures such as chemotherapy or radiotherapy, but also a treatment method which, according to studies, has a 50% chance of remission. and a tumor burden reduction of 40%. The advantage of a cancer vaccination is obvious: no rejection and purely natural with minimal non-lasting side effects. If the quality of life is maintained, the autologous dendritic cells are able to be used as sole therapy or in combination therapies.

We offer our physicians/clinics the opportunity to provide their patients with personalized cancer therapy, another building block in the fight against cancer. As an international medical service provider with optimal logistics, we can supply our customers quickly and efficiently.

​

The time factor is decisive in fighting tumours
As a doctor, practice, clinic, we supply you with the necessary blood collection set from Tuesday to Friday. Blood samples for the production of autologous dendritic cells can always be collected from Monday to Wednesday. The cell suspensions are always delivered from Tuesday to Friday. The production time is 7 days. Capacity for the production of vaccines (dendritic cells) is 4 application series per day. A series of applications includes 4 x 2 injections.

Applications of dendritic cells
Since we carry the vaccine to fight tumors and metastases in us, we need a maximum of 200 ml of whole blood from adults. For children and the elderly, we need 50 to 150 ml of whole blood. The blood of the affected patient is required in the GMP laboratory in Germany for the production and propagation of dendritic cells. Further laboratories in Europe are planned.

"Prevent Cancer"
For the preventive use of autologous dendritic cells, the dendritic cells are multiplied from 200 ml whole blood and loaded with antigens. Dendritic cell prevention is performed only once. Production time 7 days with a cell proliferation of 3 to 40 million cells. Preventive "cancer vaccination" makes sense for customers who have already been diagnosed with cancer in their family. The probability of one's own illness is around 85% according to the current study situation. Thus, the chance of developing cancer is reduced by around 50-70% after a cancer vaccination.

"Combination therapy with dendritic cells"
Since the first cancer vaccinations, scientists and complementary medicine practitioners have known how to bring about a synergy against cancer with combination therapy measures. This is where the dendritic cells are produced before treatment with chemotherapy or radiotherapy. The blood is taken beforehand because the blood has not yet been contaminated by the toxins or has not been changed by radiotherapy. Studies have shown that combination therapy can reduce the side effects of chemotherapy or radiotherapy, such as less or no hair loss and less or no pain. Many patients describe that they were much more agile and full of life during chemotherapy. It was also described that the very common depressions did not occur. A combination therapy is discussed with the doctors and planned in detail. During the breaks, i.e. between the therapy units of chemotherapy or radiotherapy, a series of applications with dendritic cells is injected once a month. It was also reported that the tumor had reduced faster with the help of autologous dendritic cells. The metastases are also optimally and sustainably combated by the dendritic cells.